Building Cluely: The Viral AI Startup that raised $15M in 10 Weeks

In 2014, in "Why There Will Never Be Another Red Hat," Peter Levine argued that Red Hat’s open source business model of commercializing support and services was highly difficult to replicate. Instead, he predicted the future of open source companies would be open source-as-a-service. And today SaaS has emerged as the dominant business model.In this podcast, recorded as a hallway-style conversation as part of the a16z Innovation Summit last year, Peter chats with Red Hat CIO, Mike Kelly, about what it means to be an open source CIO today – and how even Red Hat is evolving in the open SaaS era. They cover everything from why open hybrid has become the dominant enterprise architecture to how CIOs should think about adopting new technologies to what it takes for an M&A to be successful, beyond the spreadsheets.

28 Feb 202020min

This episode covers the following -- since our previous deep-dive on the novel coronavirus outbreak -- including:practical implications for the U.S. healthcare system given how it works today, and where we might go in the future — with a16z general partner Julie Yoo, given our vantage point in tech; andhow the rt-PCR test works — with a16z bio partner Judy Savitskaya;…in conversation with Sonal Chokshi.Sources for updates at top:CDC's latest briefing February 26, 2020, transcriptWHO situation report #27  February 25, 2020 [we covered #6 and #25 on previous episodes]Sources for last week's episode:latest numbers: cases in the U.S. (CDC, as of February 17, 2020); global cases (WHO situation report #25, February 14, 2020); spike in diagnosing cases as reported in China (SCMP, Scott Gottlieb)situation & policy statements/reports: CDC summary (as of February 14, 2020); “Annual report on global preparedness for health emergencies”, WHO (Global Preparedness Monitoring Board, 2019)on definitions (of pandemics, endemics), other terms, and various naming conventions: “Understanding pandemics: What they mean, what they don’t mean, and what comes next with the coronavirus”, Helen Branswell, StatNews (February 12, 2020); on disease occurrence and levels (CDC); “misinfodemic“; best practices on naming new human infectious diseases (WHO); qPCR (Keith Robison)image: CDC test kit for COVID-19/ Wikimedia Commons

27 Feb 202021min

It's "Marketplaces Week" for us at a16z, thanks to our consumer team releasing a new index of the next industry-defining marketplaces, the Marketplace 100.  But what happens as such marketplaces and other platforms evolve over time, as do their users? This episode is a rerun of a popular conversation from a couple years ago -- featuring general partners Andrew Chen and Jeff Jordan (in conversation with Sonal Chokshi) -- on what comes after user acquisition: retention. It's all about engagement. So what are the key metrics? And if different kinds of users join a  platform over time -- what does that mean for engagement, and where do cohort analyses come in?

20 Feb 202033min

Susan shares how she learned to leverage the characteristics of her personality early in her career as assistant secretary of state [2:05]One of the important conversations Susan had with a mentor that changed the trajectory of her career [4:50]Her parent’s commitment to education, their personal backgrounds, and the legacies they created [8:10]The result of instilling self-belief into children and mastering “psychological jiu jitsu” [10:22]What the early lessons of family diplomacy taught her [14:00]The importance of strategic compartmentalization [16:48]How to approach crisis during high stakes situations [18:29]How to practice compassionate leadership while maintaining effectiveness [20:10]Hacking the concept of “work-life balance” [21:10]The required characteristics of powerful leaders [28:14]The hard things about leadership and the idea of being liked [31:20]The “middle finger story”/the time Susan stood up for herself in an important meeting [33:23]Susan talks about China’s intelligence collection in the US [39:45]A call for unity between the private, public, and academic sectors [42:54]

14 Feb 202050min

with @OzAzamTmunity1, @JorgeCondeBio, and @omnivorousreadCAR T therapy, the groundbreaking new medicines that uses engineered T-cells to attack cancer, has been so effective in childhood leukemias that we believe it may actually be a potential cure. But this isn't just one new medicine, it's an entirely new therapeutic tool—and a total paradigm shift from most traditional medicines we've seen before.Tmunity CEO Usman "Oz" Azam was previously the head of Cell and Gene Therapies at Novartis, in many ways the first CAR T company and the team brought us blood cancer CAR T-cell therapy Kymriah—the first cell-based gene therapy to be approved in the US. In this conversation, Azam discusses with a16z's general partner Jorge Conde and Hanne Tidnam what CAR T therapy really is and how it all works. The conversation begins with the “patient and cell journey” of this treatment and how this medicine is developed, manufactured, delivered to patients; why exactly it's so different traditional medicines; what it will take to make these new medicines work on more kinds of cancer, scale to more patients, and cost less; and finally, what company building lessons can be learned from building the first CAR T company of its kind from the ground up.This episode was recorded at the annual a16z Summit.

7 Feb 202028min

When we think about rebellious behavior in the context of organizations and companies, we tend to think of rebels as trouble-makers, rabble-rousers; in other words, people who make decisions and processes more difficult because they may not follow the established rules or norms. But rebel behavior can also be incredibly positive and constructive—in keeping us from stagnation, encouraging growth and learning, increasing curiosity and creativity.In this episode of the a16z Podcast, Harvard Business School Professor Francesca Gino, a social scientist who studies organizations, breaks down with a16z's Hanne Tidnam what makes rebels different in how they tend to see and do things—whether that’s cooking, flying planes, or holding board meetings—and what we can all learn from “rebel talent” to make our organizations more productive and innovative.

4 Feb 202033min

This episode of 16 Minutes on the news from a16z is all about the recent coronavirus outbreak -- or rather, a new type of coronavirus called 2019-nCoV for 2019 novel coronavirus. Since it's an ongoing and fast-developing news cycle, we take a quick snapshot for where we are, what we know, and what we don't know, and discuss the vantage point of where tech comes in. Topics covered include:definition of a virus, categories of coronavirusesorigins and spreadhow this stacks up so far against SARS and MERSspeed of sequencing, implications of genomic infospeed of information sharingR0 ("r-naught"/"nought") and what it measuresdifferent ways to think about how bad a given epidemic iscurrent moves and treatmentsOur a16z guest is Judy Savitskaya on the bio team, in conversation with Sonal Chokshi.Link sources or background readings for this episode:Centers for Disease Control and Prevention (in the U.S. Department of Health and Human Services) + typesWorld Health Organization (in the United Nations) -- situation report #6, January 26Other background readings / pieces mentioned in this episode: "Scientists are moving at record speed to create new coronavirus vaccines--but they may come too late", Jon Cohen, Science (AAAS), January 27"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", The Lancet, January 24"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin", bioRxiv, January 2 *note - preprint, NOT peer reviewed*"The deceptively simple number sparking coronavirus fears", Ed Yong, The Atlantic, January 28 *this appeared AFTER this episode was recorded, so sharing here as additional reading only*image: CDC

30 Jan 202019min

The idea of "1000 true fans" -- first proposed by Kevin Kelly in 2008 and later updated for Tools of Titans -- argued that to be a successful creator, you don’t need millions of customers or clients, but need only thousands of true fans. Such a true, diehard fan "will buy anything you produce", and as such, creators can make a living from them as long as they: (1) create enough each year to earn profit from each fan, plus it's easier and better to give existing fans more; (2) have a direct relationship with those fans, which the internet (and long tail) now make possible.But patronage models have been around forever; what's new there? How has the web evolved; and how are media, and audiences/voices finding and subscribing to each other changing as a result? If the 1000-true-fans concept is also more broadly "useful to anyone making things, or making things happen" -- then what nuances do people often miss about it? For instance: That there are also regular fans in the next concentric circle around true fans, and that the most obscure node is only one click away from the most popular node.Finally -- when you combine this big idea with another idea Kelly proposed in his most recent book The Inevitable (covered previously on this episode) on inverting attention economies so audiences monetize their attention vs. the other way around, how do we connect the dots between them and some novel thought experiments? In this hallway-style episode of the a16z Podcast, which Sonal Chokshi recorded with Kevin in our pop-up podcast booth at our most recent a16z Summit, we discuss all this and more. Because on average, we all currently surrender our attention (whether to TV, books, or whatever) for about $3 an hour. Whoa?! image: whatleydude/Flickr

27 Jan 202015min